Revascularization at the acute phase of myocardial infarction in octogenarians;Revascularisation myocardique à la phase aiguë de l'infarctus du myocarde chez les octogénaires

Archives des Maladies du Coeur et des Vaisseaux

Volumn 95, Issue 3, 2002, Pages 143-149

  Horvilleur, J ^a   Benamer, H ^a   Aubry, P ^a   Himbert, D ^a   Gaultier, C ^a   Feldman, L ^a   Steg, P G ^a   Juliard, J M ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DILATATION; CORONARY REPERFUSION; CORONARY STENT; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; REVASCULARIZATION;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036201389     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Can we provide reperfusion therapy to all unselected patients admitted with acute myocardial infarction?
2. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: The Ontario experience, 1981 to 1991
3. Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: The Multicenter Chest Pain Study Experience
4. Comparison of outcome in patients with acute myocardial infarction aged > 75 years with that in younger patients
5. Eligibility for reperfusion therapy and outcome in elderly patients with acute myocardial infarction
6. The impact of age on the incidence and prognosis of initial acute myocardial infarction: The Worcester Heart Attack Study
7. Coronary prognostic index for predicting survival after recovery from acute myocardial infarction
8. Acute myocardial infarction in hospitalized patients over age of 70
9. Treatment of myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the «real world». One-year results from a nationwide french survey
10. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
11. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency ventricular function, and survival after acute myocardial infarction
12. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients
13. Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 7 years of age
14. Results of direct percutaneous transluminal coronary angioplasty in octogenarians
15. Systematic primary angioplasty in octogenarian and older patients
16. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989)
17. Coronary artery disease in octogenarians: Contribution of coronary angiography and evaluation of therapeutic possibilities
18. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction
19. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of myocardial infarction
20. Prognosis of patients > or = 70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients > or = 70 years of age with Q-wave acute myocardial infarction
21. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction
22. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction
23. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI stent pilot trial
24. Stent implantation in acute myocardial infarction
25. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction
26. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: The EPIC Trial results
27. Long-term protection from myocardial ischemic eventsin a randomized trial of brief integrin beta3 blockade with percutaneous coroanry intervention
28. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
29. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction
30. Bleeding complications of glycoprotein IIb/IIIa receptor inhibitors